Effect of Comp on Colorectal Cancer Cell Migration
Open Access
- 14 June 2024
- conference paper
- Published by Association for Computing Machinery (ACM)
- p. 5-12
Abstract
A publicly accessible online database was utilized in this study to investigate COMP, which is aberrantly expressed in a range of malignancies. It was discovered that colorectal cancer had significant levels of COMP expression. This finding was corroborated by Western Blot and RT-qPCR analysis tests on colorectal cancer cell lines. In order to study the effect of COMP on colorectal cancer migration, we investigated the expression of mRNA and protein levels in colorectal cancer cell lines knocked down by COMP, and the effect of COMP on the migration of SW480 cell line was studied using Transwell, wound healing assay. The findings demonstrated that the migration of colorectal cancer cell lines was suppressed by COMP expression knockdown. These findings offer a theoretical foundation for the use of COMP as a novel clinical treatment target and possible marker for the identification of colorectal cancer metastases.Keywords
Funding Information
- Natural Science Foundation of Hubei Province (2022EHB035)
This publication has 19 references indexed in Scilit:
- P4HA2 involved in SLUG-associated EMT predicts poor prognosis of patients with KRAS-positive colorectal cancerMedical Molecular Morphology, 2024
- The cross talk of ubiquitination and chemotherapy tolerance in colorectal cancerJournal of Cancer Research and Clinical Oncology, 2024
- Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer typesClinical and Translational Oncology, 2022
- Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 studyThe Lancet Oncology, 2022
- Cartilage Oligomeric Matrix Protein, COMP may be a Better Prognostic Marker Than CEACAM5 and Correlates With Colon Cancer Molecular Subtypes, Tumor Aggressiveness and Overall SurvivalJournal of Surgical Research, 2022
- Comprehensive review of targeted therapy for colorectal cancerSignal Transduction and Targeted Therapy, 2020
- Cartilage oligomeric matrix protein (COMP) promotes cell proliferation in early-onset colon cancer tumorigenesisSurgical Endoscopy, 2019
- Colorectal cancerThe Lancet, 2019
- Immunotherapy in colorectal cancer: rationale, challenges and potentialNature Reviews Gastroenterology & Hepatology, 2019
- COMP-angiopoietin-1 ameliorates inflammation-induced lymphangiogenesis in dextran sulfate sodium (DSS)-induced colitis modelJournal of Molecular Medicine, 2018